Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/23900
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhuravlyova, Larysa-
dc.contributor.authorKulikova, Mariia-
dc.date.accessioned2019-09-12T07:17:20Z-
dc.date.available2019-09-12T07:17:20Z-
dc.date.issued2019-
dc.identifier.citationZhuravlyova L. The influance of dapagliflosin on The level of blood pressure in patients with type 2 diabetes mellitus and arterial hypertension / L. Zhuravlyova, M. Kulikova // 29th European Meeting on Hypertension and Cardivascular protection, Milan, Italy, june 21–24, 2019. – Milan, 2019. – P. 157.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/23900-
dc.description.abstractThe combination of type 2 diabetes mellitus (DM-2) and arterial hypertension (AH) increases the risk of development of cardiovascular complications in 2-3 times. One of the mechanisms for the development of DM-2 is the increasing of the reabsorption of glucose by the kidneys, that is why we have the introduction into the practice of new class of oral hypoglycemic drugs - sodium-glucose co-transporter 2 inhibitors (SGLT2).ru_RU
dc.language.isoenru_RU
dc.subjectdapagliflozinru_RU
dc.subjectblood pressureru_RU
dc.subjecttype 2 diabetes mellitusru_RU
dc.subjectarterial hypertensionru_RU
dc.titleThe influance of dapagliflosin on the level of blood pressure in patients with type 2 diabetes mellitus and arterial hypertensionru_RU
dc.typeThesisru_RU
Appears in Collections:Наукові праці. Кафедра внутрішньої медицини № 3 та ендокринології

Files in This Item:
File Description SizeFormat 
THE_INFLUENCE_OF_DAPAGLIFLOSIN_ON_THE_LEVEL_OF.438.pdf173,3 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.